Plasma Leptin and Leptin Receptor Expression in Childhood Acute Lymphoblastic Leukemia

Abstract

Recently, leptin has been shown to play a regulatory role for differentiation within the myeloid and erythroid cell lineage, whereas results of its regulatory effects on lymphocytes and related tumor cells have been contradictory. To investigate whether leptin plays a role in acute lymphoblastic leukemia (ALL), we investigated the levels of leptin in plasma with enzymelinked immunosorbent assays and the expression of the leptin receptor on malignant lymphoblasts with reverse transcriptase polymerase chain reaction (RT-PCR). At diagnosis, the leptin levels of bone marrow-derived plasma in children with ALL were found to be significantly lower than the levels of healthy control subjects (0.92 ± 0.79 ng/mL versus 3.01 ± 2.27 ng/mL, respectively). Notably, at complete hematologic remission (at day 33 of chemotherapy), leptin levels had normalized to 2.6 ± 2.4 ng/mL. To elucidate the underlying mechanism of this phenomenon, we analyzed the expression of the leptin receptor on the mononuclear cell populations of the patients. RT-PCR analysis revealed gene expression rates of 33% at diagnosis versus 71% at remission, compared with 100% for healthy control subjects. Results of immunohistochemical staining supported these findings by showing that the tumor clones themselves do not express the leptin receptor. Finally, some hypotheses that might explain the decrease of leptin levels in the presence of the tumor clone are discussed.Int J Hematol. 2002;76:446-452.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin stimulates proliferation and activation of human circulating monocytes.Cell Immunol. 1999;194:6–11.

    Article  PubMed  CAS  Google Scholar 

  2. 2.

    Gainsford T, Willson TA, Metcalf D, et al. Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells.Proc Natl Acad Sci U S A. 1996;93:14564–14568.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. 3.

    Umemoto Y, Tsuji K, Yang FC, et al. Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells.Blood. 1997;90:3438–3443.

    PubMed  CAS  Google Scholar 

  4. 4.

    Bennett BD, Solar GP, Yuan JQ,Mathias J, Thomas GR, Matthews W. A role for leptin and its cognate receptor in hematopoiesis.Curr Biol. 1996;6:1170–1180.

    Article  PubMed  CAS  Google Scholar 

  5. 5.

    Cioffi JA, Shafer AW, Zupancic TJ, et al. Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction.Nat Med. 1996;2:585–589.

    Article  PubMed  CAS  Google Scholar 

  6. 6.

    Nakao T, Hino M, Yamane T, Nishizawa Y, Morii H, Tatsumi N. Expression of the leptin receptor in human leukaemic blast cells.Br J Haematol. 1998;102:740–745.

    Article  PubMed  CAS  Google Scholar 

  7. 7.

    Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis.J Leukoc Biol. 2000;68:437–446.

    PubMed  CAS  Google Scholar 

  8. 8.

    Martin-Romero C, Santos-Alvarez J, Goberna R, Sanchez-Margalet V. Human leptin enhances activation and proliferation of human circulating T lymphocytes.Cell Immunol. 2000;199:15–24.

    Article  PubMed  CAS  Google Scholar 

  9. 9.

    Laharrague P, Truel N, Fontanilles AM, Corberand JX, Penicaud L, Casteilla L. Regulation by cytokines of leptin expression in human bone marrow adipocytes.Horm Metab Res. 2000;32:381–385.

    Article  PubMed  CAS  Google Scholar 

  10. 10.

    Wex H, Vorwerk P, Mohnike K, et al. Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone.Br J Cancer. 1998;78:515–520.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. 11.

    Rothe G, Schmitz G. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies: Working Group on Flow Cytometry and Image Analysis.Leukemia. 1996;10: 877–895.

    PubMed  CAS  Google Scholar 

  12. 12.

    Gainsford T, Alexander WS. A role for leptin in hemopoieses?Mol Biotechnol. 1999;11:149–158.

    Article  PubMed  CAS  Google Scholar 

  13. 13.

    Lopez-Soriano J, Carbo N, Tessitore L, Lopez-Soriano FJ, Argiles JM. Leptin and tumor growth in rats.Int J Cancer. 1999;81:726–729.

    Article  PubMed  CAS  Google Scholar 

  14. 14.

    Tessitore L, Vizio B, Jenkins O, et al. Leptin expression in colorectal and breast cancer patients.Int J Mol Med. 2000;5:421–426.

    PubMed  CAS  Google Scholar 

  15. 15.

    Konopleva M, Mikhail A, Estrov Z, et al. Expression and function of leptin receptor isoforms in myeloid leukemia and myelodysplastic syndromes: proliferative and anti-apoptotic activities.Blood. 1999;93:1668–1676.

    PubMed  CAS  Google Scholar 

  16. 16.

    Gottschling-Zeller H, Birgel M, Scriba D, Blum WF, Hauner H. Depot-specific release of leptin from subcutaneous and omental adipocytes in suspension culture: effect of tumor necrosis factoralpha and transforming growth factor-beta1.Eur J Endocrinol. 1999;141:436–442.

    Article  PubMed  CAS  Google Scholar 

  17. 17.

    Fawcett RL, Waechter AS, Williams LB, et al. Tumor necrosis factor-alpha inhibits leptin production in subcutaneous and omental adipocytes from morbidly obese humans.J Clin Endocrinol Metab. 2000;85:530–535.

    PubMed  CAS  Google Scholar 

  18. 18.

    Kurzrock R.The role of cytokines in cancer-related fatigue.Cancer. 2001;92(suppl):1684–1688.

    Article  PubMed  CAS  Google Scholar 

  19. 19.

    Tisdale MJ. Wasting in cancer.J Nutr. 1999;129(suppl 1S): 243S-246S.

    Article  PubMed  CAS  Google Scholar 

  20. 20.

    Matthys P, Billiau A. Cytokines and cachexia.Nutrition. 1997;13: 763–770.

    Article  PubMed  CAS  Google Scholar 

  21. 21.

    Lerario DD, Ferreira SR, Miranda WL, Chacra AR. Influence of dexamethasone and weight loss on the regulation of serum leptin levels in obese individuals.Braz J Med Biol Res. 2001;34: 479–487.

    Article  PubMed  CAS  Google Scholar 

  22. 22.

    Nishiyama M, Makino S, Suemaru S, et al. Glucocorticoid effects on the diurnal rhythm of circulating leptin levels.Horm Res. 2000; 54:69–73.

    PubMed  CAS  Google Scholar 

  23. 23.

    Masuzaki H, Ogawa Y, Hosoda K, et al. Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing’s syndrome.J Clin Endocrinol Metab. 1997;82: 2542–2547.

    PubMed  CAS  Google Scholar 

  24. 24.

    Laferrere B, Fried SK, Hough K, Campbell SA, Thornton J, Pi-Sunyer FX. Synergistic effects of feeding and dexamethasone on serum leptin levels.J Clin Endocrinol Metab. 1998;83:3742–3745.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. 25.

    Heuck C, Wolthers OD. Serum leptin in children with asthma treated with inhaled budesonide.Respir Med. 1999;93:268–271.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding authors

Correspondence to Heike Wex or Edita Ponelis or Thomas Wex or Regina Dressendörfer or Uwe Mittler or Peter Vorwerk.

About this article

Cite this article

Wex, H., Ponelis, E., Wex, T. et al. Plasma Leptin and Leptin Receptor Expression in Childhood Acute Lymphoblastic Leukemia. Int J Hematol 76, 446–452 (2002). https://doi.org/10.1007/BF02982810

Download citation

Key words

  • Leukemia
  • Leptin
  • Leptin receptor
  • Blood cells
  • RT-PCR
  • ELISA